BT8009

E1266362 UNEXPLORED

BT8009 is an experimental cancer therapy developed by Bicycle Therapeutics, based on their bicyclic peptide platform to selectively target and kill tumor cells.

All labels observed (1)

Label Occurrences
BT8009 canonical 1

How this entity was disambiguated

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.